Original Source(s)
Related Content
HHS Announces Department-Wide Clinical Trial Initiative
Agency-wide effort targets US clinical trial timelines, enrollment, and regulatory barriers.
June 23, 2026
-
7 min
FDA Expands CAPVAXIVE Pediatric Use
Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.
June 18, 2026
-
2 min
FDA Grants Traditional Approval to Iptacopan in Primary IgAN
Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.
July 17, 2026
-
2 min
